Table 1 Descriptive data of the study subjects divided in groups according to the use of hormone replacement therapy (HRT).
Baseline | Two-year follow-up | |||||
|---|---|---|---|---|---|---|
HRT (106) | Non-HRT (55) | Significance between groups | HRT (106) | Non-HRT (55) | Significance between groups | |
Mean age | 55.4 ± 2.7 | 55.9 ± 2.4 | ns. | 57.4 ± 2.7 | 57.9 ± 2.4 | ns. |
Current smoker | 23(22%) | 11(20%) | ns. | 19(18%) | 8 (15%) | ns. |
Current climateric symptoms | 16 (15%) | 24 (44%) | p < 0.001 | 14 (13%) | 19 (35%) | p < 0.001 |
Satisfactory self-assesed dental health | 65 (61%) | 28 (51%) | ns. | 63 (59%) | 31 (56%) | ns. |
Diagnosed illness: | ||||||
Cardiovascular disease | 19 (18%) | 10 (18%) | ns. | 25 (24%) | 11 (20%) | ns. |
Psychiatric disease | 1 (1%) | 2 (4%) | ns. | 1 (1%) | 3 (6%) | ns. |
Asthma | 8 (8%) | 3 (6%) | ns. | 12 (11%) | 3 (6%) | ns. |
Rheumatic disease | 8 (8%) | 2 (4%) | ns. | 6 (6%) | 3 (6%) | ns. |
Regular medication: | ||||||
Use of cardiovascular drugs# | 29 (27%) | 14 (26%) | ns. | 39 (37%) | 14 (26%) | ns. |
Use of neurological drugs# | 7 (7%) | 10 (18%) | p < 0.05 | 5 (5%) | 9 (16%) | p < 0.05 |
Use of respiratory drugs# | 7 (7%) | 4 (7%) | ns. | 15 (14%) | 4 (7%) | ns. |
Use of analgesics and antipyretics | 7 (7%) | 1 (2%) | ns. | 5 (5%) | 5 (9%) | ns. |
Allergy medication | 4 (4%) | 0 (0%) | ns. | 0 | 0 | - |
Oestrogen therapy | 49 (47%) | 47 (47%) | ||||
Progestin therapy | 2 (2%) | 1 (1%) | ||||
Combination therapy | 53 (51%) | 53 (53%) | ||||